News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current NLLSF market cap is 751.91M. The company's latest EPS is NOK -0.5118 and P/E is -0.88.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Revenue | 569.71M | 651.88M | 795.75M | 993.58M | 1.77B |
| Operating Income | -282.17M | -406.88M | -585.14M | -1.28B | -585.62M |
| Net Income | -269.71M | 1.26B | -1.67B | -1.17B | -855.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Total Assets | 2.43B | 6.14B | 6.01B | 6.95B | 7.86B |
| Total Liabilities | 584.06M | 668.38M | 968.28M | 1.5B | 1.66B |
| Total Equity | 1.85B | 5.47B | 5.04B | 5.45B | 6.2B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | NOK (kr) | |
| Operating | -209.23M | -215.89M | -449.46M | -690.58M | -669.67M |
| Investing | -134.12M | -294.43M | -373.62M | -403.09M | -646.81M |
| Financing | 519.5M | 2.31B | 1.22B | 1.49B | 1.54B |
| Market Cap | 751.91M |
| Price to Earnings Ratio | -0.88 |
| Price to Sales Ratio | 0.43 |
| Price to Cash Ratio | 0.22 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 1.67B |
| Average Volume (1 week) | 51.5k |
| Average Volume (1 Month) | 35.48k |
| 52 Week Change | -66.91% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.408 |
| Spread (Intraday) | 0.09 (16.67%) |
| Company Name | Nel ASA (PK) |
| Address |
karenslyst all�� 20 oslo N-0212 |
| Website | https://www.nelhydrogen.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
